SGS partnership helps clients to beat pharmaceutical counterfeiting
Partnership will provide SGS clients with a unique additional analytical service that uses cutting-edge technology to verify product authenticity, process authenticity and product/process infringement.
SGS has entered into a partnership with Nature’s Fingerprint, a Connecticut-based division of Molecular Isotope Technologies, specializing in product and process authentication via natural tracers, to mitigate identity theft of bio/pharmaceutical products and the patented synthetic pathways by which they are produced.
Counterfeiting of products and infringement of patented processes are multi-billion dollar problems for the bio/pharmaceutical industry and their global supply chain. This partnership will enable SGS to provide its clients with a unique additional analytical service that uses cutting-edge technology to verify product authenticity, process authenticity and product/process infringement.
Nature’s Fingerprint’s technology relies on the precise determination of stable isotope ratios (naturally existing tracers) obtained by combustion and mass spectrometric analyses of either bulk phases or specific compounds. The expertise of Nature’s Fingerprint’s scientific team is in the innovative application of these methodologies to bio/pharmaceutical products and processes, ranging from process authentication to raw material provenance identification and manufacturing process discrimination.
“Through this partnership, SGS now has the capability to enhance its analytical consulting and analytical service offering, especially with regard to comparability or biosimilarity studies,” commented Mark Rogers, Global Technical Director, Life Sciences. “SGS’s unrivaled experience in this field will now extend to the selection and categorization of reference material lots and manufacturing process profiling.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance